Sandra Gendler, Ph.D. is on the Scientific Advisory Board of OncoTAb. She is a Professor of Biochemistry and Molecular Biology at the Mayo Clinic and was recognized for distinction in her field by the appointment of the David F. and Margaret T. Grohne Research Professorship in Therapeutics in Cancer Research. She originally cloned the gene for the MUC1 tumor antigen and she is now translating MUC1-specific therapy into the clinic.
View in org chart
View in org chart
Current role